Condition
Neuroendocrine Tumor Carcinoid clinical trials and research
Research outlook What's coming for Neuroendocrine tumors: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Neuroendocrine Tumor Carcinoid clinical trials that are recruiting, at sites in 2 countries (most in Brazil (1), France (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
How medicines are managed during targeted radioligand cancer treatment
This project tracks how pharmacists and nuclear medicine teams manage medications and provide pharmaceutical advice for adults receiving targeted radioligand treatments like Lutathera and Pluvicto.
-
Comparing two doses of Everolimus for treating neuroendocrine tumors
This study is testing whether a lower dose of Everolimus can effectively treat patients with advanced neuroendocrine tumors while causing fewer side effects compared to a higher dose.
Related topics
Quick answers
How many Neuroendocrine Tumor Carcinoid clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Brazil (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.